S. Llerena

发表

Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C.

M. Buti, R. Andrade, X. Forns, 2017, Journal of hepatology.

HCV Management in the Incarcerated Population: How Do We Deliver on This Important Front?

S. Llerena, J. Crespo, A. Cuadrado, 2019, Current Hepatology Reports.

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.

X. Forns, S. Llerena, J. Calleja, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It

S. Llerena, J. Crespo, E. Fábrega, 2019, Cells.

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease

S. Llerena, J. Crespo, D. San Segundo, 2016, International journal of molecular sciences.

Improved health outcomes from hepatitis C treatment scale-up in Spain’s prisons: A cost-effectiveness study

T. Ayer, J. Chhatwal, M. Roberts, 2018 .

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA‐C real‐world cohort

M. Fernández-Bermejo, S. Llerena, M. Bonacci, 2018, Journal of viral hepatitis.

LOXL2—A New Target in Antifibrogenic Therapy?

S. Llerena, J. Crespo, E. Fábrega, 2019, International journal of molecular sciences.

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.

F. Jorquera, J. Ampuero, S. Llerena, 2017, Journal of hepatology.

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

X. Forns, M. Vergara, S. Llerena, 2017, The American Journal of Gastroenterology.

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.

S. Llerena, J. Crespo, E. Fábrega, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

J. Bruix, X. Forns, B. Sangro, 2019, Journal of hepatology.

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

S. Llerena, J. Crespo, E. Fábrega, 2019, Journal of clinical medicine.

Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real‐life cohort

M. Buti, J. Ampuero, S. Llerena, 2017, Journal of viral hepatitis.

Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences

S. Llerena, J. Crespo, A. Cuadrado, 2021, Diagnostics.

Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do

S. Llerena, J. Calleja, J. Crespo, 2020, Journal of viral hepatitis.

Strategy for the Elimination of Hepatitis C in Cantabria.

S. Llerena, J. Crespo, A. Cuadrado, 2020, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding

S. Llerena, J. Crespo, E. Fábrega, 2018, World journal of clinical cases.

Rescue Therapy for Genotype-3 DAA Non-responders, Almost all Done.

S. Llerena, J. Crespo, A. Cuadrado, 2018, Annals of hepatology.

Resistance to hepatitis C virus. Implications and therapeutic options

S. Llerena, J. Crespo, P. Iruzubieta, 2017 .

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.

S. Llerena, J. Crespo, E. Fábrega, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain

J. Lazarus, J. Llorca, S. Llerena, 2019, Journal of viral hepatitis.

Plasma betatrophin levels in patients with liver cirrhosis.

S. Llerena, J. Crespo, E. Fábrega, 2015, World journal of gastroenterology.